Using opioid-sparing pain management techniques to better prevent addiction and abuse

Over 2 million people each year switch to persistent opioid use after surgery, and nearly half of all U.S. opioid overdose deaths involve a prescription opioid. The American Association of Nurse Anesthetists (AANA) is calling on the healthcare community at large to utilize opioid-sparing pain management techniques to better prevent opioid addiction and abuse.

"The American opioid crisis is one of the most pressing healthcare issues of our time, and more than ever the healthcare community needs to come together to modernize opioid-prescribing criteria and utilize more effective, evidence-based solutions to pain management practices, to help prevent opioid addiction," said Bruce Weiner, a Certified Registered Nurse Anesthetist (CRNA) and president of the AANA.

One such approach is Enhanced Recovery After Surgery (ERAS) – a patient-centered, evidence-based, pain management strategy employed by CRNAs to reduce the need for opioids, improve patient outcomes and reduce cost. Rather than relying on opioids as the primary tool, ERAS uses robust patient communication and opioid-sparing techniques, such as regional anesthesia, peripheral nerve blocks, non-pharmacologic approaches and non-opioid medications to control pain. Recent research also shows:

  • ERAS provides an average savings of $880 to $5,560 per patient. ERAS reduces patient length of stay by 3-4 days on average.
  • ERAS reduces 30-day patient readmission rates and costs.
  • ERAS helps patients return to normal activities more quickly.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare